DE379516T1 - Hyperimmun globulin gegen hiv. - Google Patents

Hyperimmun globulin gegen hiv.

Info

Publication number
DE379516T1
DE379516T1 DE198888908090T DE88908090T DE379516T1 DE 379516 T1 DE379516 T1 DE 379516T1 DE 198888908090 T DE198888908090 T DE 198888908090T DE 88908090 T DE88908090 T DE 88908090T DE 379516 T1 DE379516 T1 DE 379516T1
Authority
DE
Germany
Prior art keywords
hyperimmun
against hiv
globulin against
globulin
hiv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE198888908090T
Other languages
English (en)
Inventor
M. Laurence Libertyville Il 60048 Us Cummins
Jean-Pierre F-75001 Paris Fr Allain
A. Jr. Lawrence Waukegan Il 60085 Us Falk
M. Richard Minneapolis Mn 55405 Us Condie
H. Jr. Henry Minneapolis Mn 55427 Us Balfour
S. Frank Minneapolis Mn 55414 Us Rhame
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
University of Minnesota
Original Assignee
Abbott Laboratories
University of Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories, University of Minnesota filed Critical Abbott Laboratories
Publication of DE379516T1 publication Critical patent/DE379516T1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1054—Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DE198888908090T 1987-08-11 1988-08-10 Hyperimmun globulin gegen hiv. Pending DE379516T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8442687A 1987-08-11 1987-08-11
PCT/US1988/002768 WO1989001339A1 (en) 1987-08-11 1988-08-10 Hyper-immune globulin against hiv

Publications (1)

Publication Number Publication Date
DE379516T1 true DE379516T1 (de) 1991-01-17

Family

ID=22184901

Family Applications (2)

Application Number Title Priority Date Filing Date
DE198888908090T Pending DE379516T1 (de) 1987-08-11 1988-08-10 Hyperimmun globulin gegen hiv.
DE88908090T Expired - Fee Related DE3884811T2 (de) 1987-08-11 1988-08-10 Hyperimmun globulin gegen hiv.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE88908090T Expired - Fee Related DE3884811T2 (de) 1987-08-11 1988-08-10 Hyperimmun globulin gegen hiv.

Country Status (11)

Country Link
EP (1) EP0379516B1 (de)
JP (1) JPH0796560B2 (de)
KR (1) KR970003056B1 (de)
AU (1) AU618555B2 (de)
DE (2) DE379516T1 (de)
DK (1) DK35290A (de)
FI (1) FI900670A0 (de)
IE (1) IE62584B1 (de)
NO (1) NO180271C (de)
NZ (1) NZ225796A (de)
WO (1) WO1989001339A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2640511B1 (fr) * 1988-12-15 1993-04-23 Merieux Inst Medicaments pour le traitement ou la prevention par immunisation passive de l'infection par le virus hiv et procede de preparation
EP0826005B1 (de) 1996-03-12 2004-05-12 Ovogenix Immunpharma GmbH Verwendung von aviären, vitellinen, gegen hiv-antigene gerichteten antikörpern zur herstellung pharmazeutischer zubereitungen
WO1998001476A1 (en) * 1996-07-10 1998-01-15 Nabi Highly synergistic neutralization of hiv through combinations of monoclonal and polyclonal antibodies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE54757T1 (de) * 1985-02-05 1990-08-15 Us Commerce Verfahren zum nachweis von htlv-iii neutralisierenden antikoerpern in sera.
AU592142B2 (en) * 1985-11-25 1990-01-04 Cytogen Corporation Modified viral glycoproteins, diagnostic and therapeutic uses therefore
EP0287226A1 (de) * 1987-03-23 1988-10-19 Hiver Limited Impfstoff

Also Published As

Publication number Publication date
EP0379516A1 (de) 1990-08-01
NO180271B (no) 1996-12-09
IE882455L (en) 1989-02-11
KR890701133A (ko) 1989-12-19
NO900674D0 (no) 1990-02-12
NO900674L (no) 1990-02-12
IE62584B1 (en) 1995-02-08
EP0379516B1 (de) 1993-10-06
KR970003056B1 (ko) 1997-03-14
DE3884811D1 (de) 1993-11-11
NO180271C (no) 1997-03-19
AU2322588A (en) 1989-03-09
NZ225796A (en) 1991-08-27
JPH02504514A (ja) 1990-12-20
JPH0796560B2 (ja) 1995-10-18
AU618555B2 (en) 1992-01-02
FI900670A0 (fi) 1990-02-09
DE3884811T2 (de) 1994-02-24
DK35290D0 (da) 1990-02-09
DK35290A (da) 1990-02-09
WO1989001339A1 (en) 1989-02-23

Similar Documents

Publication Publication Date Title
NO883395D0 (no) Mikrobicid mikroemulsjon.
DE3862564D1 (de) Erdanker.
DE3867976D1 (de) Polymergebundene antioxydationsmittel.
IT8821018A0 (it) Proietto.
DE3876873T2 (de) Weblitzenuebergabevorrichtung.
DE3785663D1 (de) Loetgeraet.
DE3876304D1 (de) Polysilacylobutasilazane.
DE3869101D1 (de) Faltwerk.
DE3886320T2 (de) Kreuzleger.
FI890874A0 (fi) Expression av hiv-bindningsproteiner.
DE3870513D1 (de) Tennisball.
DE3862309D1 (de) Aminomethyltetrahydrofurane.
DE3868433D1 (de) Tribuenengeruest.
DE3861694D1 (de) Cyclopropancarboxamide.
DE3853279T2 (de) Laryngoskop.
DE68919242D1 (de) Kondensator.
DE3866192D1 (de) Zusammengesetztes faltblatt.
DE3860307D1 (de) 2-aminomethyltetrahydrofurane.
DE3884811D1 (de) Hyperimmun globulin gegen hiv.
FI890892A0 (fi) B-amylasgen.
DE3866770D1 (de) Gerbstoff.
DE3873615D1 (de) Polycyanoarylthioether.
DE3867805D1 (de) Paraocclusaler loeffel.
FI912635A0 (fi) Expression av hiv-proteiner i drosophila-celler.
ATE95428T1 (de) Hyperimmun globulin gegen hiv.